 |
Minimalna wpłata $50 Ekskluzywna promocja |
Nasz wynik |
0% prowizja |
Are you looking to buy Horizon Therapeutics Public stocks? Chech our Reportlab with an in-depth review, check prices, statistics and see if buying this stock is interesting right now. This article will help you buy NASDAQ:HZNP! and analyze the company to see if this stock might be an interesting option to invest in. We will enlighten you about Horizon Therapeutics Public stocks and how to buy and use them. Click on the button to start reading the review right now or scroll down for real time statistics about this company.
Horizon Therapeutics Public Limited Company, a biopharmaceutical company, focuses on researching, developing, and commercializing of medicines that address unmet treatment needs for rare and rheumatic diseases in the United States and internationally. Its orphan and rheumatology marketed medicines include KRYSTEXXA, a medicine for the treatment of uncontrolled gout; RAVICTI for use as a nitrogen-binding agent for chronic management of adult and pediatric patients; PROCYSBI for nephropathic cystinosis, a rare and life-threatening metabolic disorder; ACTIMMUNE for chronic granulomatous disease; RAYOS for the treatment of rheumatoid arthritis (RA), polymyalgia rheumatic, systemic lupus erythematosus, and various other indications; BUPHENYL tablets for oral administration and BUPHENYL powder for oral, nasogastric, or gastrostomy tube administration; and QUINSAIR, a formulation of the antibiotic drug levofloxacin for the management of chronic pulmonary infections due to Pseudomonas aeruginosa in adult patients with cystic fibrosis. The company also offers PENNSAID 2% that is indicated for the treatment of pain of osteoarthritis (OA) of the knees; DUEXIS for the relief of signs and symptoms of RA and OA, and to decrease the risk of developing upper-GI ulcers; and VIMOVO for the relief of signs and symptoms of OA, RA, and ankylosing spondylitis to decrease the risk of developing gastric ulcers in patients at risk of developing NSAID-associated gastric ulcers. It has collaboration agreements with Lupus Research and HemoShear Therapeutics, LLC. The company was formerly known as Horizon Pharma Public Limited Company and changed its name to Horizon Therapeutics Public Limited Company in May 2019. Horizon Therapeutics Public Limited Company was founded in 2005 and is headquartered in Dublin, Ireland.
Średnia wielkość
2.10 million shs
KAPITAŁ RYNKOWY
$19.25 billion
Giełda Papierów Wartościowych
NASDAQ
Proszę kupić te akcje!
|
NAZWA
|
TICKER
|
PRZEMYSŁ
|
SEKTOR
|
VOLUME
|
KUP TERAZ TĘ AKCJĘ
|
|---|---|---|---|---|---|
|
NASDAQ:HZNP
|
Preparaty farmaceutyczne
|
Medyczny
|
21,252 shs
|
Below is a quick guide on how to buy NASDAQ:HZNP stocks safe, fast and around the world in less than five minutes.
Krok 1: Otworzyć rachunek w eToro – eToro is the best broker to buy Horizon Therapeutics Public shares in the world as you won’t pay any commissions. To do this, visit the eToro website and open an account, it is 100% safe and they offer a huge amount of stocks.
Krok 2: Załadować Państwa ID - Zgodnie z przepisami KYC eToro poprosi Państwa o przesłanie kopii paszportu lub prawa jazdy.
Krok 3: Wpłata środków - Proszę wpłacić trochę pieniędzy na swoje nowo utworzone konto eToro. Mogą Państwo wybrać pomiędzy przelewem bankowym, e-wallet lub kartą debetową/kredytową lub Paypal.
Krok 4: Buy Horizon Therapeutics Public – Search for “”NASDAQ:HZNP”” and click on the “”Trade”” button. Enter the total amount of your investment (minimum $50) and confirm the order by clicking the “”Open Trade”” button. And that’s it: you have just bought Horizon Therapeutics Public stocks with 0% commission!.
1 | | Minimalna wpłata $50 Ekskluzywna promocja | Nasz wynik 10 ★★★★★ | 0% prowizja |
8 Wall Street analysts have issued “buy,” “hold,” and “sell” ratings for Horizon Therapeutics Public in the last year. There are currently 8 buy ratings for the stock. The consensus among Wall Street analysts is that investors should “buy” Horizon Therapeutics Public stock.
Wall Street analysts have given Horizon Therapeutics Public a “Buy” rating, but there may be better short-term opportunities in the market. Some of Reportlab’s past winning trading ideas have resulted in 5-15% weekly gains. Reportlab just released five new trading ideas, but Horizon Therapeutics Public wasn’t one of them. Reportlab thinks five stocks may be even better buys in the how to buy stocks guide.
1 | | Minimalna wpłata $50 Ekskluzywna promocja | Nasz wynik 10 ★★★★★ | 0% prowizja |
2 |  | Minimalna wpłata $50 Ekskluzywna promocja | Nasz wynik 10 ★★★★★ | 0% prowizja |
3 |  | Minimalna wpłata $50 Ekskluzywna promocja | Nasz wynik 10 ★★★★★ | 0% prowizja |
It can be difficult to navigate through all the outdated and incorrect information related to purchasing NASDAQ:HZNP stocks. We believe that stocks should be accessible for all, which is why we’ve created this handy guide on where to buy Horizon Therapeutics Public stocks with a step by step approach.
You’ll need to register with a broker, in these times you can’t go without once and it’s crucial to use a regulated broker that’s allowed to operate there, otherwise, you risk losing funds. eToro is one such broker, and one of the best brokers to buy Horizon Therapeutics Public stocks with 0% comission, to sign up just click on open account in the following table or compare other options.
Ponieważ eToro jest platformą regulowaną, musi Pan wypełnić proces KYC, jest to standardowa procedura i zajmuje tylko kilka minut. Musi Pan przedstawić dowód tożsamości ze zdjęciem (paszport, prawo jazdy) oraz dowód adresu (rachunek za media, wyciąg z banku).
Po zarejestrowaniu się i zweryfikowaniu konta, należy wpłacić środki. eToro akceptuje karty kredytowe/debetowe, przelewy bankowe, a także e-wallety. Tak więc niezależnie od Państwa preferencji znajdzie się coś dla Państwa.
Now that you’ve funded your eToro account, just type “NASDAQ:HZNP stocks" w pasku wyszukiwania na górze ekranu i nacisnąć "handel".
All that’s left is to buy some NASDAQ:HZNP stock. Simply enter the amount you want to purchase and hit the “buy” button. The amount you bought will be automatically credited to your account where you can monitor its performance.
All in all, NASDAQ:HZNP is an incredibly interesting company that has the potential to solve some major issues in the business space. After reading this guide you should know how to buy this investment using the best broker or platform. We recommend eToro to anyone looking for a regulated, easy-to-use, fully-featured broker to buy Horizon Therapeutics Public stocks. As with any broker or online platform, it’s crucial you set up 2FA when using their tools as it ensures your funds are completely safe.
Horizon Therapeutics Public is scheduled to release its next quarterly earnings announcement on Wednesday, February 24th 2021.
View our earnings forecast for Horizon Therapeutics Public.
Horizon Therapeutics Public will be holding an earnings conference call on Wednesday, February 24th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.
Horizon Therapeutics Public Limited (NASDAQ:HZNP) announced its quarterly earnings data on Saturday, November, 7th. The biopharmaceutical company reported $1.74 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.97 by $0.77. The biopharmaceutical company had revenue of $636.40 million for the quarter, compared to analysts’ expectations of $531.11 million. Horizon Therapeutics Public had a trailing twelve-month return on equity of 25.66% and a net margin of 43.55%. Horizon Therapeutics Public’s revenue for the quarter was up 89.4% compared to the same quarter last year. During the same period last year, the company posted $0.64 earnings per share.
View Horizon Therapeutics Public’s earnings history.
Horizon Therapeutics Public’s stock was trading at $30.51 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, HZNP stock has increased by 179.3% and is now trading at $85.22.
Launched in 2006, eToro is, in our opinion, without a doubt the best broker for buying NASDAQ:HZNP stocks in the world. The onboarding process is simple, it’s designed to make sure even those new to the stock market are ready to start investing the shortest amount of time possible. As a regulated platform you gain several benefits, most importantly, you know they’re not going to run off with your hard-earned money./
Ponad 95% środków klientów jest przechowywanych w trybie offline, w zimnym magazynie, co jest kluczowe dla każdego brokera, który zarządza Państwa aktywami. Niezależnie od tego, jak bezpieczna ma być platforma, zalecamy stosowanie 2FA, aby dodać dodatkową warstwę bezpieczeństwa do Państwa konta.
eToro oferuje użytkownikom szereg funkcji, aby mogli Państwo jak najszybciej zacząć inwestować. Mają Państwo stosunkowo unikalną funkcję copy trading, która pozwala na uzyskanie pasywnego dochodu poprzez odzwierciedlanie doświadczonych traderów, co pozwala szybko zacząć zarabiać i daje lepsze zrozumienie strategii stosowanych przez profesjonalistów. Dodatkowo eToro umożliwia użytkownikom inwestowanie w zarządzane portfele, przy czym zarządzany portfel to różne podobne aktywa zgrupowane razem, co pozwala na dywersyfikację konta i zmniejsza ewentualne ryzyko. Dla tych, którzy mają już doświadczenie w handlu, mogą Państwo inwestować na rynkach poza akcjami, ponieważ eToro pozwala użytkownikom na handel ETF-ami, towarami, kryptowalutami i indeksami. Jeżeli już inwestują Państwo poza przestrzenią giełdową, może to być bardzo przydatne, ponieważ pozwala to na zarządzanie wszystkimi Państwa inwestycjami w jednym miejscu.
Horizon Therapeutics Public updated its FY 2020 IntraDay earnings guidance on Monday, February, 1st. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $2.14 billion, compared to the consensus revenue estimate of $2.14 billion.
8 Wall Street analysts have issued 1 year target prices for Horizon Therapeutics Public’s shares. Their forecasts range from $51.00 to $112.00. On average, they anticipate Horizon Therapeutics Public’s share price to reach $93.67 in the next twelve months. This suggests a possible upside of 9.9% from the stock’s current price.
View analysts’ price targets for Horizon Therapeutics Public or view top-rated stocks among Wall Street analysts.
CFD są złożonymi instrumentami i wiążą się z wysokim ryzykiem szybkiej utraty pieniędzy z powodu dźwigni finansowej. 68% kont inwestorów detalicznych traci pieniądze przy handlu CFD u tego dostawcy. Powinni Państwo rozważyć, czy rozumieją Państwo, jak działają kontrakty CFD i czy mogą sobie Państwo pozwolić na wysokie ryzyko utraty pieniędzy.
Horizon Therapeutics Public saw a decline in short interest in the month of January. As of January 15th, there was short interest totaling 5,950,000 shares, a decline of 20.0% from the December 31st total of 7,440,000 shares. Based on an average daily volume of 2,630,000 shares, the days-to-cover ratio is presently 2.3 days.
View Horizon Therapeutics Public’s Short Interest.
Horizon Therapeutics Public’s management team includes the following people:
Mr. Timothy P. Walbert, Chairman, Pres & CEO (Age 54, Pay $4.73M)
Mr. Paul W. Hoelscher, Exec. VP & CFO (Age 56, Pay $1.67M)
Mr. Barry J. Moze, Exec. VP & Chief Admin. Officer (Age 67, Pay $1.46M)
Mr. Vikram Karnani, Exec. VP & Pres of International (Age 46, Pay $1.34M)
Mr. Miles W. McHugh, Chief Accounting Officer & Sr. VP (Age 56)
Dr. Karin Rosen M.D., Ph.D., Exec. VP of R&D and Chief Scientific Officer
Ms. Tina E. Ventura, Sr. VP of Investor Relations
Mr. Brian K. Beeler, Exec. VP & Gen. Counsel (Age 48)
Mr. Timothy Ayers, Chief Compliance Officer & VP
Mr. Geoffrey M. Curtis, Exec. VP of Corp. Affairs & Chief Communications Officer (Age 46)
70 employees have rated Horizon Therapeutics Public CEO Timothy Walbert on Glassdoor.com. Timothy Walbert has an approval rating of 73% among Horizon Therapeutics Public’s employees.
Some companies that are related to Horizon Therapeutics Public include Johnson & Johnson (JNJ), Pfizer (PFE), Eli Lilly and (LLY), AbbVie (ABBV), Merck & Co., Inc. (MRK), Bristol-Myers Squibb (BMY), Zoetis (ZTS), Royalty Pharma (RPRX), Jazz Pharmaceuticals (JAZZ), Perrigo (PRGO), Nektar Therapeutics (NKTR), Corcept Therapeutics (CORT), Pacira BioSciences (PCRX), Endo International (ENDP) and Supernus Pharmaceuticals (SUPN).
View all of HZNP’s competitors.
1 | | Minimalna wpłata $50 Ekskluzywna promocja | Nasz wynik 10 ★★★★★ | 0% prowizja |
Based on aggregate information from Reportlab watchlists, some companies that other Horizon Therapeutics Public investors own include Alibaba Group (BABA), NVIDIA (NVDA), OPKO Health (OPK), Advanced Micro Devices (AMD), Netflix (NFLX), Gilead Sciences (GILD), Tesla (TSLA), AbbVie (ABBV), Micron Technology (MU) and PayPal (PYPL).
Horizon Therapeutics Public trades on the NASDAQ under the ticker symbol “HZNP.”
Horizon Therapeutics Public’s stock is owned by a number of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (6.44%), Congress Asset Management Co. MA (0.84%), Victory Capital Management Inc. (0.53%), Frontier Capital Management Co. LLC (0.50%), Scout Investments Inc. (0.44%) and Jennison Associates LLC (0.38%). Company insiders that own Horizon Therapeutics Public stock include Barry Moze, Brian K Beeler, Daniel A Camardo, Geoffrey M Curtis, Irina Konstantinovsky, James Samuel Shannon, Jeff Kent, Jeffrey W Sherman, Michael A Desjardin, Michael G Grey, Miles W Mchugh, Paul W Hoelscher, Timothy P Walbert and Vikram Karnani.
View institutional ownership trends for Horizon Therapeutics Public.
HZNP stock was sold by a variety of institutional investors in the last quarter, including Emerald Advisers LLC, Emerald Mutual Fund Advisers Trust, Victory Capital Management Inc., Frontier Capital Management Co. LLC, Columbus Circle Investors, Rhenman & Partners Asset Management AB, AJO LP, and Russell Investments Group Ltd.. Company insiders that have sold Horizon Therapeutics Public company stock in the last year include Barry Moze, Brian K Beeler, Daniel A Camardo, Irina Konstantinovsky, Jeff Kent, Jeffrey W Sherman, Michael A Desjardin, Michael G Grey, Miles W Mchugh, Paul W Hoelscher, Timothy P Walbert, and Vikram Karnani.
View insider buying and selling activity for Horizon Therapeutics Public or view top insider-selling stocks.
HZNP stock was bought by a variety of institutional investors in the last quarter, including BlackRock Inc., C WorldWide Group Holding A S, GW&K Investment Management LLC, Swiss National Bank, Kornitzer Capital Management Inc. KS, Braun Stacey Associates Inc., Artemis Investment Management LLP, and Jabodon PT Co..
View insider buying and selling activity for Horizon Therapeutics Public or or view top insider-buying stocks.
Shares of HZNP can be purchased through any online brokerage account. Popular online brokerages with access to the stock market include Interactive Brokers Review, eToro Review, Przegląd DEGiro, AvaTrade Review, IG Markets Review, IC Markets Review, CMC Markets Review, Admiral Markets Review i wiele innych. Proszę przeczytać jedną z recenzji, aby dowiedzieć się wszystkiego o brokerze i zacząć kupować akcje już teraz.
Na Reportlab.org chcemy się upewnić, że mają Państwo wszystkie najbardziej istotne informacje na temat kupno akcji. Przynosimy Państwu najlepsze przewodniki po giełdzie z osobistymi opiniami, informacjami uzupełniającymi, opiniami o platformach, how to's i więcej. Chcą Państwo uzyskać inne informacje? Proszę zajrzeć na stronę Akcje OTC, Akcje NASDAQ, Akcje na NYSE, Akcje LON, Akcje FRA, Akcje ETR, Zapasy EPA, Akcje TSX lub Akcje Amex. Szukam bardziej szczegółowych informacji, takich jak 5g zapasy, akcje biotechnologiczne, akcje złota i inne informacje z naszego Reportlab.
How can you buy Horizon Therapeutics Public stock on the internet?
You can easily buy Horizon Therapeutics Public stocks with one of the well known regulated brokers on the internet. You can open an account within 5 minutes, make deposits with countless payment providers and trade with professional tools on their platform. At the moment, our visitors rate eToro as the most popular choice.
Inną opcją jest skorzystanie z usług regulowanego brokera, jak np. IC Markets lub Interactive Brokers. You can an account with these brokers and start buying or trading NASDAQ:HZNP stocks in a safe and complete environment to trade in.
Where to buy Horizon Therapeutics Public stock?
You will first want to find a licensed broker that supports NASDAQ:HZNP stock. One of our favourite brokers, eToro for example, allows you to make investments into this asset from just $25 and only charges you the spread. Another option is using a regulated broker like DEGIRO or Interactive Brokers. You can open an account with these brokers and start buying or trading NASDAQ:HZNP stocks in a safe and complete environment.
Is NASDAQ:HZNP stock a good investment?
As with any other asset, there is an element of risk associated with buying NASDAQ:HZNP stocks. Therefore, you will want to study the market and make a decision based on your financial standing and the risk you are willing to take.
Is Horizon Therapeutics Public stock safe to invest in?
All stocks are volatile, or affected by market circumstances. The case with NASDAQ:HZNP is no different, with its price fluctuating dramatically within short periods. As such, if the market goes against you, then you will end up facing a loss. We advice you to do research first before investing in Horizon Therapeutics Public stock.
How do you trade Horizon Therapeutics Public stocks?
You can trade stocks by first opening an account with a regulated platform and making a deposit in US dollars, EUROs or other currency. Next, search for Horizon Therapeutics Public stock and choose from a buy or sell order – depending on whether you think the stock asset will rise or fall in value. If you speculated on NASDAQ:HZNP stocks correctly, you will have made a profit. The size of your trading profit will ultimately be determined by your stake and at what percentage your position grew.
How to sell Horizon Therapeutics Public stock?
To sell your NASDAQ:HZNP stocks investment, you can sign in to your broker account and cash out directly from within your portfolio. If you have stored the stocks elsewhere, you will first have to transfer them to a third-party provider or broker to cash out.
What is the best Horizon Therapeutics Public stock trading platform?
eToro, is a top-rated platform for beginners, albeit, it charges significantly lower fees. For example, there are no fees to deposit with a debit/credit card and you only need to cover the spread when trading NASDAQ:HZNP stock.
Stephen wie wiele o produktach finansowych, a w szczególności pasjonuje się rynkami giełdowymi i ich uczestnikami. Mamy nadzieję, że przedstawione informacje będą dla Państwa pomocne. Coś nie jest całkiem jasne? Proszę zostawić swoje pytania lub komentarze na dole strony.
| Nasz wynik ★★★★★ | |
| Nasz wynik ★★★★★ | |
| Nasz wynik ★★★★★ |
Newsletter
Najnowsze wiadomości
| |
Nasz wynik |
0% prowizja |
Dane o akcjach i kryptowalutach w czasie rzeczywistym
Powiadomienia, Porady & Nowości
Best Stocks & Crypto Guides
Recenzje brokerów i giełd online
Reportlab Finance jest stroną czysto informacyjną i w żadnym wypadku nie oznacza doradztwa inwestycyjnego. Wszystkie inwestycje niosą ze sobą ryzyko i mogą Państwo stracić wszystkie swoje inwestycje. Proszę nie inwestować pieniędzy, na których utratę nie mogą sobie Państwo pozwolić.
Reportlab Finance
38 Holburn Lane
Heckfield Green
IP21 0UB
Zjednoczone Królestwo
Copyright © 2022 Reportlab.Finance | Wszystkie prawa zastrzeżone.
